Cost –utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
ConclusionAll more invasive strategies were found to increase life expectancy and quality of life of women with aBRCA1 orBRCA2mutation and were cost-saving for the Swiss healthcare system compared to IS.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research
More News: Cancer | Cancer & Oncology | Economics | Health Management | Mastectomy | Ovarian Cancer | Ovaries | Switzerland Health | Women